The facility will manufacture Avastin (bevacizumab) and Herceptin.
-
Genentech, a subsidiary of Roche, has purchased the Longa plant in Singapore... -
The merged plants will focus on producing drugs for the treatment of... -
The combined facility is situated in Singapore's Tuas Biomedical Park, a hub... -
Genentech's 1,000l E coli manufacturing plant will produce Lucentis. -
The facility will manufacture Avastin (bevacizumab) and Herceptin.
Twitter